Adventrx Pharmaceuticals, Inc.
Pharmaceutical firm reports loss of $0.04 per share
Published in Lab Business Week, May 1st, 2005
For the fourth quarter of 2004, Adventrx reported a net loss of $2.4 million, or $0.04 per share, compared with a net loss of $795,000, or $0.02 per share, for the fourth quarter of 2003. For the year ended December 31, 2004, net loss was $6.7 million, or $0.13 per share, compared with a net loss of $2.4 million, or $0.07 per share, for the same period in 2003.
"Our most significant accomplishment during the past year was hitting the primary clinical endpoint of response rate for our phase II metastatic colorectal cancer trial with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2005-05-01)
More Articles from Lab Business Week
- Adams Laboratories, Inc.
Pharmaceutical company announces initial public offering - Adherex Technologies, Inc.
Oncology company reports loss of $0.06 per share - Agennix Incorporated
Pharmaceutical firm raises $22M in private financing - Altachem Pharma, Ltd.
Pharmaceutical firm receives $1M from debentures financing - AmerisourceBergen Corporation
Pharmaceutical services company announces share repurchase transaction - BioMS Medical Corp.
Multiple sclerosis drug developer raises $41.4M in offering - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
